Table of Contents
Lung Cancer International
Volume 2016, Article ID 6787648, 7 pages
http://dx.doi.org/10.1155/2016/6787648
Review Article

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

1Oncodéfi, Parc Euromédecine, 209 avenue des Apothicaires, Parc Euromédecine, 34 090 Montpellier, France
2Team Biostatistics Epidemiology Public Health, EA 2415, University Institute for Clinical Research, 34 093 Montpellier, France
3Medical Oncology Department, Hôpital Henri Mondor, AP-HP, 51 avenue du Maréchal de Lattre de Tassigny, 94 010 Créteil, France
4Pierre et Marie Curie University, Paris, France
5Radiotherapy Service, Institut de Cancérologie Val d’Aurelle, Parc Euromédecine, 208 avenue des Apothicaires, 34 298 Montpellier, France
6Department of Fundamental Health Sciences, Health Sciences University of Hokkaido, Tobetsu, Hokkaido 061-0293, Japan
7Descartes University, Paris, France
8Unit of Thoracic Oncology Service, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75 014 Paris, France

Received 29 March 2016; Revised 17 June 2016; Accepted 4 September 2016

Academic Editor: Natasha B. Leighl

Copyright © 2016 Daniel Satgé et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. W. Coppus, “People with intellectual disability: What do we know about adulthood and life expectancy?” Developmental Disabilities Research Reviews, vol. 18, no. 1, pp. 6–16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Satgé, A. J. Sasco, B. Azema et al., “Cancers in persons with intellectual deficiency: current data,” in Mental Retardation Research Focus, M. V. Charleton, Ed., pp. 47–84, Nova Sciences Publisher, New York, NY, USA, 2007. View at Google Scholar
  3. NHS Health Scotland Health Needs Assessment Report, People with Learning Disabilities in Scotland, NHS Scotland Glasgow, 2015.
  4. K. Patja, P. Eero, and M. Iivanainen, “Cancer incidence among people with intellectual disability,” Journal of Intellectual Disability Research, vol. 45, no. 4, pp. 300–307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. G. Sullivan, R. Hussain, T. Threlfall, and A. H. Bittles, “The incidence of cancer in people with intellectual disabilities,” Cancer Causes and Control, vol. 15, no. 10, pp. 1021–1025, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Kiani, F. Tyrer, A. Shaikh, C. W. McGrother, and D. Satgé, “Cancer deaths in people with moderate to profound intellectual disabilities: the Leicestershire experience 1993–2006,” International Journal of Child Health and Human Development, vol. 3, no. 2, pp. 215–221, 2010. View at Google Scholar
  7. M. P. Jancar and J. Jancar, “Cancer and intellectual disability,” Bristol Medico-Chirurgical Journal, vol. 92, no. 341/342, pp. 3–7, 1977. View at Google Scholar
  8. J. Jancar, “Cancer and mental handicap. A further study (1976–85),” British Journal of Psychiatry, vol. 156, pp. 531–533, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. L. B. Cooke, “Cancer and learning disability,” Journal of Intellectual Disability Research, vol. 41, no. 4, pp. 312–316, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. K. F. O'Brien, K. Tate, and E. S. Zaharia, “Mortality in a large Southeastern facility for persons with mental retardation,” American Journal on Mental Retardation, vol. 95, no. 4, pp. 397–403, 1991. View at Google Scholar · View at Scopus
  11. D. Satgé, E. Merrick-Kenig, I. Kandel et al., “Cancer mortality in residential care centers for persons with intellectual disability in Israel 1991–2005,” International Journal of Child Health and Human Development, vol. 3, pp. 213–228, 2010. View at Google Scholar
  12. H. M. Evenhuis, “Medical aspects of ageing in a population with intellectual disability: III. Mobility, internal conditions and cancer,” Journal of Intellectual Disability Research, vol. 41, no. 1, pp. 8–18, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. G. S. Lohiya, H. Pirkle, H. Nguyen, S. Lohiya, and T. Vuu, “Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions,” Western Journal of Medicine, vol. 148, no. 4, pp. 426–429, 1988. View at Google Scholar · View at Scopus
  14. D. Satgé, S. Salmeron, T. Homsi, M.-O. Réthoré, and J. Tredaniel, “Adenocarcinoma of the lung in Down syndrome: first clinical report,” Tumori, vol. 99, no. 4, pp. e169–e171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. R. P. Cole, H. E. Hughes, M. J. Jeffreys, G. T. Williams, and M. M. Arnold, “Small cell lung carcinoma in a patient with Sotos syndrome: are genes at 3p21 involved in both conditions?” Journal of Medical Genetics, vol. 29, no. 5, pp. 338–341, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Nenekidis, G. T. Stathopoulos, V. Anagnostakou et al., “Atypical pulmonary carcinoid tumour in a 28-year-old nonsmoker with Prader-Willi syndrome,” European Respiratory Journal, vol. 38, no. 5, pp. 1230–1233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Casanova, A. Selicorni, and A. Ferrari, “Cancer predisposition in children with Kabuki syndrome,” American Journal of Medical Genetics Part A, vol. 155, no. 6, p. 1504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Moreno Pérez, F. J. García Martín, R. Vázquez López et al., “Nijmegen breakage syndrome associated with pulmonary lymphoma,” Anales Espanoles de Pediatria, vol. 57, no. 6, pp. 574–577, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Liehr, K. Mrasek, H. Starke, U. Claussen, and G. Schreiber, “Unusual small supernumerary marker chromosome (sSMC) 9 in a Klinefelter patient,” Cytogenetic and Genome Research, vol. 111, no. 2, pp. 179–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. N. B. McGillicuddy, “A review of substance use research among those with mental retardation,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 12, no. 1, pp. 41–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Hymowitz, F. E. Jaffe, A. Gupta, and M. Feuerman, “Cigarette smoking among patients with mental retardation and mental illness,” Psychiatric Services, vol. 48, no. 1, pp. 100–102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Tracy and R. Hosken, “The importance of smoking education and preventative health strategies for people with intellectual disability,” Journal of Intellectual Disability Research, vol. 41, no. 5, pp. 416–421, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. B. E. Mcguire, P. Daly, and F. Smyth, “Lifestyle and health behaviours of adults with an intellectual disability,” Journal of Intellectual Disability Research, vol. 51, no. 7, pp. 497–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. S. Taylor, P. J. Standen, P. Cutajar, D. Fox, and D. N. Wilson, “Smoking prevalence and knowledge of associated risks in adult attenders at day centres for people with learning disabilities,” Journal of Intellectual Disability Research, vol. 48, no. 3, pp. 239–244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. P. Burtner, M. D. Wakham, D. R. McNeal, and T. P. Garvey, “Tobacco and the institutionalized mentally retarded: usage choices and ethical considerations,” Special Care in Dentistry, vol. 15, no. 2, pp. 56–60, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kerr, M. Lawrence, C. Darbyshire, A. R. Middleton, and L. Fitzsimmons, “Tobacco and alcohol-related interventions for people with mild/moderate intellectual disabilities: a systematic review of the literature,” Journal of Intellectual Disability Research, vol. 57, no. 5, pp. 393–408, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Hasle, A. Mellemgaard, J. Nielsen, and J. Hansen, “Cancer incidence in men with Klinefelter syndrome,” British Journal of Cancer, vol. 71, no. 2, pp. 416–420, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Swerdlow, M. J. Schoemaker, C. D. Higgins et al., “Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study,” Journal of the National Cancer Institute, vol. 97, no. 16, pp. 1204–1210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Scholl, Z. Stein, and H. Hansen, “Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976,” Developmental Medicine and Child Neurology, vol. 24, no. 6, pp. 817–829, 1982. View at Google Scholar · View at Scopus
  30. H. Hasle, J. M. Friedman, J. H. Olsen, and S. A. Rasmussen, “Low risk of solid tumors in persons with Down syndrome,” Genetics in Medicine, 2016. View at Publisher · View at Google Scholar
  31. K. Pátja, E. Pukkala, R. Sund, M. Iivanainen, and M. Kaski, “Cancer incidence of persons with Down syndrome in Finland: a population-based study,” International Journal of Cancer, vol. 118, no. 7, pp. 1769–1772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. G. Sullivan, R. Hussain, E. J. Glasson, and A. H. Bittles, “The profile and incidence of cancer in Down syndrome,” Journal of Intellectual Disability Research, vol. 51, no. 3, pp. 228–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. J. Sasco, S. M. Day, N. Voirin, D. J. Strauss, R. M. Shavelle, and D. Satgé, “Cancer mortality in Down syndrome in California,” International Journal on Disability and Human Development, vol. 7, no. 4, pp. 413–424, 2008. View at Google Scholar · View at Scopus
  34. H. Yamada, K. Yanagisawa, S. Tokumaru et al., “Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer,” Genes Chromosomes & Cancer, vol. 47, no. 9, pp. 810–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. E. de Graaff, R. Willemsen, N. Zhong et al., “Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor,” The American Journal of Human Genetics, vol. 57, no. 3, pp. 609–618, 1995. View at Google Scholar · View at Scopus
  36. D. Satgé, C. Vérité, B. N. Bui et al., “A review of malignancies in fragile X syndrome and report of an Ewing sarcoma,” International Journal on Disability and Human Development, vol. 7, no. 4, pp. 441–445, 2008. View at Google Scholar · View at Scopus
  37. R. Sund, E. Pukkala, and K. Patja, “Cancer incidence among persons with fragile X syndrome in Finland: a population-based study,” Journal of Intellectual Disability Research, vol. 53, no. 1, pp. 85–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Lucá, M. Averna, F. Zalfa et al., “The Fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation,” EMBO Molecular Medicine, vol. 5, no. 10, pp. 1523–1536, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Schoemaker, A. J. Swerdlow, C. D. Higgins, A. F. Wright, and P. A. Jacobs, “Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study,” The Lancet Oncology, vol. 9, no. 3, pp. 239–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. C. Murphy, W. E. Berdon, C. Ruzal-Shapiro et al., “Malignancies in pediatric patients with ataxia telangiectasia,” Pediatric Radiology, vol. 29, no. 4, pp. 225–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. F. X. McCornack and E. P. Henske, “Lymphangiomyomatosis and pulmonary diseases in Tuberous sclerosis,” in Tuberous Sclerosis Complex, D. J. Kiatowski, V. H. Whittemore, and E. A. Thiele, Eds., pp. 345–368, Willey-Blackwell, Weinheim, Germany, 2010. View at Google Scholar
  42. A. Diamanti, C. Noto, A. Magistrelli et al., “Association between gastroesophageal reflux and endobronchial carcinoid: a case report,” Thoracic and Cardiovascular Surgeon, vol. 59, no. 3, pp. 186–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Kiani, A. Vahabzadeh, E. A. Hepplewhite et al., “Overcoming challenges in diagnosing and treating cancers in people with intellectual disability: a case analysis,” Tizard Learning Disability Review, vol. 19, no. 2, Article ID 17107567, pp. 51–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Kaako and V. O. Kolade, “Back pain and mental retardation,” Tennessee Medicine, vol. 103, no. 8, pp. 37–43, 2010. View at Google Scholar · View at Scopus
  45. I. Tuffrey-Wijne, J. Bernal, J. Hubert, G. Butler, and S. Hollins, “People with learning disabilities who have cancer: an ethnographic study,” British Journal of General Practice, vol. 59, no. 564, pp. 503–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Tuffrey-Wijne, Living with Learning Disabilities, Dying with Cancer. Thirteen Personal Stories, Jessica Kingsley Publisher, London, UK, 2010.
  47. K. Hoffmann, B. Kretschmar, V. Buller, and P. Kermer, “Craniopharyngioma resulting in pituitary gland insufficiency and coma in an adult with intellectual disability and severe challenging behavior,” The Journal of Neuropsychiatry & Clinical Neurosciences, vol. 22, no. 4, pp. 451.e18–451.e19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Tuffrey-Wijne and J. Davies, “This is my story: I've got cancer: ‘the Veronica project’: an ethnographic study of the experiences of people with learning disabilities who have cancer,” British Journal of Learning Disabilities, vol. 35, no. 1, pp. 7–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. L. M. Hanna, L. Taggart, and W. Cousins, “Cancer prevention and health promotion for people with intellectual disabilities: an exploratory study of staff knowledge,” Journal of Intellectual Disability Research, vol. 55, no. 3, pp. 281–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Satgé, E.-A. Sauleau, W. Jacot et al., “Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma,” BMC Cancer, vol. 14, article 150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Satgé, P. Clémenson, M. Nishi et al., “A mucoepidermoid carcinoma in a young man with intellectual disability: review of oral cancer in people with intellectual disability,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 115, no. 5, pp. e22–e27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Annable, D. Stienstra, and H. M. Chochinov, “Ebrary CEL-York University, Canadian Partnership Against Cancer, & Canadian Electronic Library (Firm),” Addressing disability in cancer care, Toronto, Ontario, Canada: Canadian Partnership Against Cancer, 2010, https://www.library.yorku.ca/find/Record/3121714.
  53. J. Foster and B. Marks, “Commentary on ‘overcoming challenges in diagnosing and treating cancers in people with intellectual disability: a case analysis’,” Tizard Learning Disability Review, vol. 19, no. 2, Article ID 171075678, pp. 59–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. G. M. Bernstein and S. K. Offenbartl, “Adverse surgical outcomes among patients with cognitive impairments,” The American Surgeon, vol. 57, no. 11, pp. 682–690, 1991. View at Google Scholar · View at Scopus
  55. P. O'Regan and E. Drummond, “Cancer information needs of people with intellectual disability: a review of the literature,” European Journal of Oncology Nursing, vol. 12, no. 2, pp. 142–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. S. G. McNeeley and T. E. Elkins, “Gynecologic surgery and surgical morbidity in mentally handicapped women,” Obstetrics and Gynecology, vol. 74, no. 2, pp. 155–158, 1989. View at Google Scholar · View at Scopus
  57. L. I. Iezzoni, L. H. Ngo, D. Li, R. G. Roetzheim, R. E. Drews, and E. P. McCarthy, “Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer,” Archives of Physical Medicine and Rehabilitation, vol. 89, no. 4, pp. 595–601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Kawakami, A. Kobayashi, M. Bando et al., “A case of juvenile lung cancer with suspected progeroid syndrome and mental retardation,” The Journal of the Japanese Respiratory Society, vol. 45, no. 3, pp. 272–276, 2007. View at Google Scholar · View at Scopus
  59. N. Uchisaka, N. Takahashi, M. Sato et al., “Two brothers with ataxia-telangiectasia-like disorder with lung adenocarcinoma,” The Journal of Pediatrics, vol. 155, no. 3, pp. 435–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Tuffrey-Wijne, J. Bernal, and S. Hollins, “Disclosure and understanding of cancer diagnosis and prognosis for people with intellectual disabilities: findings from an ethnographic study,” European Journal of Oncology Nursing, vol. 14, no. 3, pp. 224–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Hemsley and S. Balandin, “A metasynthesis of patient-provider communication in hospital for patients with severe communication disabilities: informing new translational research,” Augmentative and Alternative Communication, vol. 30, no. 4, pp. 329–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Gilbert, T. Wilkinson, and S. Crudgington, “Supporting people with intellectual disability in the cancer journey: the ‘Living with cancer’ communication pack,” European Journal of Oncology Nursing, vol. 11, no. 4, pp. 357–361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. V. Cobigo, H. Ouellette-Kuntz, R. Balogh, F. Leung, E. Lin, and Y. Lunsky, “Are cervical and breast cancer screening programmes equitable? The case of women with intellectual and developmental disabilities,” Journal of Intellectual Disability Research, vol. 57, no. 5, pp. 478–488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Tuffrey-Wijne, R. Whelton, L. Curfs, and S. Hollins, “Palliative care provision for people with intellectual disabilities: a questionnaire survey of specialist palliative care professionals,” Palliative Medicine, vol. 22, no. 3, pp. 281–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. A. Feldman, J. Bosett, C. Collet, and P. Burnham-Riosa, “Where are persons with intellectual disabilities in medical research? A survey of published clinical trials,” Journal of Intellectual Disability Research, vol. 58, no. 9, pp. 800–809, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. T. J. Van Hoof and W. B. Taggart, “Mental retardation and decision making: balancing autonomy and protection,” Connecticut Medicine, vol. 62, no. 8, pp. 455–460, 1998. View at Google Scholar · View at Scopus
  67. S. Flynn, L. Hulbert-Williams, R. Bramwell, D. Stevens-Gill, and N. Hulbert-Williams, “Caring for cancer patients with an intellectual disability: attitudes and care perceptions of UK oncology nurses,” European Journal of Oncology Nursing, vol. 19, no. 5, pp. 568–574, 2015. View at Publisher · View at Google Scholar · View at Scopus